Exactly right. Auditors would question why not impairing the carrying value compared to the decline in MC.
I also posted here before Simon Hay started that he would most likely push for non cash impairments. All new CEO’s do, they want a clean slate and have the lowest starting point on as many metrics as possible, how else can he look like a hero in the future.
My only surprise is that its not more TBH.
- Forums
- ASX - By Stock
- GXY
- Ann: Non-Cash Impairment
Ann: Non-Cash Impairment, page-12
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GXY (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online